Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|December 31, 2005
Parental decision making in pediatric cancer end-of-life care: using focus group methodology as a prephase to seek participant design inputDeborah Tomlinson, Michael Capra, Janet Gammon, et al.
Translational Oncology|May 27, 2018
Hypoxia-Targeting Drug Evofosfamide (TH-302) Enhances Sunitinib Activity in Neuroblastoma Xenograft ModelsSushil Kumar, Jessica D Sun, Libo Zhang, et al.
Journal of Pediatric Hematology/Oncology|May 17, 2019
MYCN Amplified Relapse Following Resolution of MYCN Nonamplified 4S Neuroblastoma With Placental Involvement: A Case Report and Review of the LiteratureKarin P S Langenberg-Ververgaert, Samuele Renzi, Catherine T Chung, et al.
Cancer Chemotherapy and Pharmacology|December 20, 2011
Tolerability and pharmacokinetic profile of a sunitinib powder formulation in pediatric patients with refractory solid tumors: a Children's Oncology Group studySteven G DuBois, Suzanne Shusterman, Joel M Reid, et al.
Pediatric Blood & Cancer|November 6, 2018
Phase I study of vinblastine and temsirolimus in pediatric patients with recurrent or refractory solid tumors: Canadian Cancer Trials Group Study IND.218Rebecca J Deyell, Bing Wu, S Rod Rassekh, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 19, 2011
Chemotherapy versus supportive care alone in pediatric palliative care for cancer: comparing the preferences of parents and health care professionalsDeborah Tomlinson, Ute Bartels, Janet Gammon, et al.
Contrast Media & Molecular Imaging|November 4, 2017
Correlation of Somatostatin Receptor-2 Expression with Gallium-68-DOTA-TATE Uptake in Neuroblastoma Xenograft ModelsLibo Zhang, Douglass C Vines, Deborah A Scollard, et al.
European Journal of Cancer (Oxford, England : 1990)|July 27, 2010
A multi-centre Canadian pilot study of metronomic temozolomide combined with radiotherapy for newly diagnosed paediatric brainstem gliomaJulia R Sharp, Eric Bouffet, Diana Stempak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Protracted intermittent schedule of topotecan in children with refractory acute leukemia: a pediatric oncology group studyWayne L Furman, Clinton F Stewart, Mark Kirstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
High-Dose celecoxib and metronomic "low-dose" cyclophosphamide is an effective and safe therapy in patients with relapsed and refractory aggressive histology non-Hodgkin's lymphomaRena Buckstein, Robert S Kerbel, Yuval Shaked, et al.
Pageof 8